Hypofractionated Radiotherapy for Breast Cancer

Please read this page completely before beginning the activity. If you have any questions or need further information, please call the Memorial Sloan Kettering Cancer Center's CME Office at 646-227-2025.
Hypofractionated Radiotherapy for Breast Cancer

Beryl McCormick discusses current information about hypofractionated radiation therapy for breast cancer, its rationale, clinical evidence, and future directions.

Course Information

Lecture Date
June 2008
Target Audience

This program is directed toward all physicians involved in the treatment of patients with cancer but primarily towards radiation oncologists.

Educational Objectives

Participants will receive important current information about hypofractionated radiation therapy for breast cancer, its rationale, clinical evidence and future directions.